Valor clínico de la biopsia líquida de alta sensibilidad: real word data experience con OncoBEAM en CCRm

12 / 30

A comprehensive panel required: a Pilot study with Amplicon-seq in mCRC
n=90 (RAS mutant enriched)
NGS VHIO-card (Amplicon-seq), 60 genes
65 samples with available BEAMing test:
25 WT by BEAMing, 21 by NGS (3 likely FP)
40 mutant by BEAMing, 33 by NGS (7 missed by NGS MAF <0.5%)
r2 0.7